Investor Relations Home

Profile
IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 70 independent distributors into over 100 countries.
Stock Quote
IRIX (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$8.95
Change (%) Stock is Down 0.08 (0.89%)
Volume70,449
Data as of 05/22/17 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
DateTitle 
05/04/17IRIDEX Announces Presentation Of Data Demonstrating Safety And Efficacy Of Micropulse® Technology At Upcoming Industry Conferences
Results will be highlighted at upcoming ASCRS congress May 5-9 and ARVO annual meeting May 7-11 MOUNTAIN VIEW, Calif., May 4, 2017 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced the presentation of data demonstrating the safety and efficacy of its proprietary MicroPulse® technology for treating glaucoma and retinal disease at the upcoming American Society of Cataract and Refractive Surgery Symposium & Congress (ASCRS) and Association for Research in Vision and Ophthalmo... 
Printer Friendly Version
05/03/17IRIDEX Announces First Quarter 2017 Financial Results
Updates Guidance for Full Year 2017 MOUNTAIN VIEW, Calif., May 3, 2017 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the three months ended April 1, 2017. Recent Financial Results and Highlights Total revenue of $10.5 million for the first quarter of 2017, a 12% decrease year over year Cyclo G6™ glaucoma laser platform revenues in the first quarter of 2017 grew in the low double digits year over year ... 
Printer Friendly Version
04/19/17IRIDEX to Report First Quarter 2017 Financial Results on May 3, 2017
MOUNTAIN VIEW, Calif., April 19, 2017 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced that it will release financial results for the first quarter 2017 after the close of trading on Wednesday, May 3, 2017.  The Company's management team will host a corresponding conference call beginning at 2:30 p.m. PT / 5:30 p.m. ET. Investors interested in listening to the conference call may do so by dialing (844) 707-0665 for domestic callers or (703) 3... 
Printer Friendly Version
03/15/17IRIDEX To Present At The Sidoti & Co. Spring 2017 Convention
MOUNTAIN VIEW, Calif., March 15, 2017 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to participate in the Sidoti & Co. Spring 2017 Convention in New York, NY. Iridex's management is scheduled to present on Wednesday, March 29, 2017 at 3:00pm ET. Interested parties can access the live webcast at www.IRIDEX.com. An archived presentation will also be available on the Company's website. About IRIDEX IRIDEX Corporation... 
Printer Friendly Version
Primary IR Contact
Lynn Lewis or Leigh Salvo
Phone: (415) 937-5404
E-mail: investors@iridex.com


Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.


logo aa0logo agslogo ascrslogo asrslogo esrs0logo euretina